456 related articles for article (PubMed ID: 27347925)
1. Role of the Renin-Angiotensin-Aldosterone System beyond Blood Pressure Regulation: Molecular and Cellular Mechanisms Involved in End-Organ Damage during Arterial Hypertension.
Muñoz-Durango N; Fuentes CA; Castillo AE; González-Gómez LM; Vecchiola A; Fardella CE; Kalergis AM
Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27347925
[TBL] [Abstract][Full Text] [Related]
2. Arterial stiffness and the renin-angiotensin-aldosterone system.
Mahmud A; Feely J
J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):102-8. PubMed ID: 15526244
[TBL] [Abstract][Full Text] [Related]
3. Role of the renin-angiotensin-aldosterone system in vascular remodeling and inflammation: a clinical review.
Duprez DA
J Hypertens; 2006 Jun; 24(6):983-91. PubMed ID: 16685192
[TBL] [Abstract][Full Text] [Related]
4. The relationship of plasma renin, angiotensin, and aldosterone levels to blood pressure variability and target organ damage in children with essential hypertension.
Liu Y; Lin Y; Zhang MM; Li XH; Liu YY; Zhao J; Shi L
BMC Cardiovasc Disord; 2020 Jun; 20(1):296. PubMed ID: 32546130
[TBL] [Abstract][Full Text] [Related]
5. Hypertension and kidneys: unraveling complex molecular mechanisms underlying hypertensive renal damage.
Mennuni S; Rubattu S; Pierelli G; Tocci G; Fofi C; Volpe M
J Hum Hypertens; 2014 Feb; 28(2):74-9. PubMed ID: 23803592
[TBL] [Abstract][Full Text] [Related]
6. [Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?].
Horký K
Vnitr Lek; 2007 Apr; 53(4):364-70. PubMed ID: 17578167
[TBL] [Abstract][Full Text] [Related]
7. Developmental activity of the renin-angiotensin system during the "critical period" modulates later L-NAME-induced hypertension and renal injury.
Ishiguro K; Sasamura H; Sakamaki Y; Itoh H; Saruta T
Hypertens Res; 2007 Jan; 30(1):63-75. PubMed ID: 17460373
[TBL] [Abstract][Full Text] [Related]
8. Oxidative DNA damage in kidneys and heart of hypertensive mice is prevented by blocking angiotensin II and aldosterone receptors.
Brand S; Amann K; Mandel P; Zimnol A; Schupp N
PLoS One; 2014; 9(12):e115715. PubMed ID: 25551569
[TBL] [Abstract][Full Text] [Related]
9. [Hypertension-induced fibrosis: a balance story].
Azibani F; Fazal L; Chatziantoniou C; Samuel JL; Delcayre C
Ann Cardiol Angeiol (Paris); 2012 Jun; 61(3):150-5. PubMed ID: 22681982
[TBL] [Abstract][Full Text] [Related]
10. Role of the renin-angiotensin system in kidney development and programming of adult blood pressure.
Almeida LF; Tofteng SS; Madsen K; Jensen BL
Clin Sci (Lond); 2020 Mar; 134(6):641-656. PubMed ID: 32219345
[TBL] [Abstract][Full Text] [Related]
11. Reversal of cardiovascular structural changes when treating essential hypertension. The importance of the renin-angiotensin-aldosterone system.
Dahlöf B; Herlitz H; Aurell M; Hansson L
Am J Hypertens; 1992 Dec; 5(12 Pt 1):900-11. PubMed ID: 1337459
[TBL] [Abstract][Full Text] [Related]
12. Optimal antagonism of the Renin-Angiotensin-aldosterone system: do we need dual or triple therapy?
Werner C; Pöss J; Böhm M
Drugs; 2010 Jul; 70(10):1215-30. PubMed ID: 20568830
[TBL] [Abstract][Full Text] [Related]
13. Blockade of the renin-angiotensin-aldosterone system: effects on hypertensive target organ damage.
Grandi AM; Maresca AM
Cardiovasc Hematol Agents Med Chem; 2006 Jul; 4(3):219-28. PubMed ID: 16842207
[TBL] [Abstract][Full Text] [Related]
14. The renin-angiotensin-aldosterone system in 2011: role in hypertension and chronic kidney disease.
Simões E Silva AC; Flynn JT
Pediatr Nephrol; 2012 Oct; 27(10):1835-45. PubMed ID: 21947887
[TBL] [Abstract][Full Text] [Related]
15. Hypertension: renin-angiotensin-aldosterone system alterations.
Te Riet L; van Esch JH; Roks AJ; van den Meiracker AH; Danser AH
Circ Res; 2015 Mar; 116(6):960-75. PubMed ID: 25767283
[TBL] [Abstract][Full Text] [Related]
16. Renin-angiotensin-aldosterone (RAAS): The ubiquitous system for homeostasis and pathologies.
Patel S; Rauf A; Khan H; Abu-Izneid T
Biomed Pharmacother; 2017 Oct; 94():317-325. PubMed ID: 28772209
[TBL] [Abstract][Full Text] [Related]
17. Renin inhibition ameliorates renal damage through prominent suppression of both angiotensin I and II in human renin angiotensinogen transgenic mice with high salt loading.
Yoshida S; Ishizawa K; Ayuzawa N; Ueda K; Takeuchi M; Kawarazaki W; Fujita T; Nagase M
Clin Exp Nephrol; 2014 Aug; 18(4):593-9. PubMed ID: 24154707
[TBL] [Abstract][Full Text] [Related]
18. Green tea could improve elderly hypertension by modulating arterial stiffness, the activity of the renin/angiotensin/aldosterone axis, and the sodium-potassium pumps in old male rats.
Gao J; Akbari A; Wang T
J Food Biochem; 2022 Dec; 46(12):e14398. PubMed ID: 36181277
[TBL] [Abstract][Full Text] [Related]
19. The renin-angiotensin-aldosterone system: a specific target for hypertension management.
Weir MR; Dzau VJ
Am J Hypertens; 1999 Dec; 12(12 Pt 3):205S-213S. PubMed ID: 10619573
[TBL] [Abstract][Full Text] [Related]
20. [Regulatory mechanisms for the renin-angiotensin-aldosterone system].
Ichihara A
Nihon Rinsho; 2012 Sep; 70(9):1477-81. PubMed ID: 23012790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
